Motus GI (NASDAQ:MOTS), Inc. is a medical technology company focused on advancing gastrointestinal (GI) endoscopy through innovative device solutions. The company’s flagship product, the PURE-Vu® System, is a patented, single-use colon cleansing and irrigation system designed to enhance visualization during colonoscopy procedures by removing debris on demand. Motus GI also develops complementary accessories and procedural protocols aimed at improving clinical efficiency, reducing procedure times and lowering the need for repeat examinations.
Since its inception, Motus GI has pursued regulatory clearances and clinical validations to support adoption in hospital endoscopy suites and outpatient gastrointestinal centers. The PURE-Vu® System has received U.S. Food and Drug Administration (FDA) clearance for use in adult patients and carries a CE mark for distribution in Europe, reflecting the company’s commitment to meeting stringent safety and performance standards. Motus GI collaborates with leading GI practices and academic centers to refine its technology and integrate best practices into training and clinical workflows.
Headquartered in Fort Lauderdale, Florida, Motus GI primarily serves the U.S. market while pursuing strategic partnerships and distribution agreements to expand into Europe, the Middle East and Asia. The company maintains a dedicated sales and clinical support team that works closely with endoscopy nurses, technicians and physicians to ensure seamless implementation and to gather real-world performance data. Ongoing research initiatives explore additional applications of the PURE-Vu® platform in pediatric populations and other endoluminal procedures.
Under the guidance of a management team with deep experience in medical device innovation and gastroenterology, Motus GI continues to build its commercial footprint. Executives draw on decades of combined expertise in product development, regulatory affairs and healthcare commercialization, while clinical leadership includes practicing endoscopists who advise on procedural optimization. This collaborative approach positions Motus GI to address persistent challenges in bowel preparation and to drive higher quality outcomes in GI endoscopy.
